The University of Washington this week held an open house to celebrate the new headquarters of CoMotion, the UW organization ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and ...

The second gene therapy invented at Nationwide Children's Hospital got FDA approval last year. Here's what that meant for ...

"The company will invest $11 million in the increase of the number of stores, the expansion of its service infrastructure and the creation of new jobs in Ukraine in 2024," Ukrainian media outlets ...

Pope Francis has warned against the excessive commercialization of art and the destructive impact of the market on creativity ...

AIXI READ THE FULL AIXI RESEARCH REPORT Second Half and Full Year 2023 Results Xiao-I (NASDAQ:AIXI) reported 2023 full-year results on April 30, 2024, which we have utilized to back into the six-month ...

BANGOR — Husson University’s Brien Walton, director of the Dyke Center for Family Business, was recently invited to speak at the White House during a ...

Cytophage Technologies (TSXV: CYTO) has filed its fiscal 2023 results, providing a recap on a successful year in terms of ...

In August 2020, Alvotech and Teva entered into a strategic partnership for the exclusive commercialization of five of Alvotech’s biosimilar product candidates, and in August 2023 the partners extended ...

SES AI, a U.S. maker of electric vehicle batteries, aims to bring its next-gen lithium metal batteries to market as early as ...

Extended contract now covers a total of 11 European countries Crossject will receive milestone payments of up to €1 million in total, upon marketing authorizations Crossject will sell ZEPIZURE® to the ...

Philip Morris announces the expansion of its portfolio of smoke-free products in Ukraine and the launch of the latest version ...